DEXCOM INC·4

Mar 14, 5:39 PM ET

Lawver Teri L 4

4 · DEXCOM INC · Filed Mar 14, 2024

Insider Transaction Report

Form 4
Period: 2024-03-12
Lawver Teri L
EVP Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2024-03-12$134.41/sh4,764$640,33366,641 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]Included in this number are 60,067 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 34,014 of which were granted on March 8, 2023 and shall vest through March 8, 2027.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT